Considering an Investment in Marvell Technology (MRVL)? Read This!

We've been asking ourselves recently if the market has placed a fair valuation on Marvell Technology. Let's dive into some of the fundamental values of this large-cap Technology company to determine if there might be an opportunity here for value-minded investors.

Marvell Technology Has an Attractive P/B Ratio but a Worrisome P/E Ratio:

Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company belongs to the Technology sector, which has an average price to earnings (P/E) ratio of 35.0 and an average price to book (P/B) ratio of 7.92. In contrast, Marvell Technology has a trailing 12 month P/E ratio of -78.2 and a P/B ratio of 2.89.

Marvell Technology's PEG ratio is 2.72, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

The Business Is Unprofitable and Its Balance Sheet Is Highly Leveraged:

2021 2022 2023
Revenue (MM) $2,969 $4,462 $5,920
Revenue Growth n/a 50.3% 32.66%
Gross Margins 41% 46% 50%
Operating Margins -9% -8% 4%
Net Margins -9% -9% -3%
Net Income (MM) -$277 -$421 -$164
Net Interest Expense (MM) $69 $139 $171
Depreciation & Amort. (MM) $198 $266 $305
Earnings Per Share -$0.41 -$0.53 -$0.19
EPS Growth n/a -29.27% 64.15%
Diluted Shares (MM) 669 797 851
Free Cash Flow (MM) $710 $650 $1,083
Capital Expenditures (MM) $107 $169 $206
Current Ratio 1.81 1.31 1.03
Long Term Debt (MM) $4,557 $3,928 $3,134
Net Debt / EBITDA -64.96 -46.31 8.07

Marvell Technology has slimmer gross margins than its peers, consistently negative margins with a positive growth rate, and a highly leveraged balance sheet. On the other hand, the company benefits from growing revenues and increasing reinvestment in the business and a strong EPS growth trend. Furthermore, Marvell Technology has irregular cash flows.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS